Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: Diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2
- 1 November 1990
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 31 (6) , 358-364
- https://doi.org/10.1007/bf01741407
Abstract
Summary We have previously reported that both regressor (QR) and progressor (metastatic, QP) clones were obtained after the in vitro exposure of a mouse fibrosarcoma BMT-11 cl-9 to quercetin [17]. In this study, we investigated possible mechanisms of spontaneous regression of QR clones as compared with tumorigenic QP and BMT-11 cl-9 tumor clones. We observed that BMT-11 cl-9 cells produced relatively high amounts of prostaglandin E2 (PGE2) during in vitro culture. The average production by 11 subclones of BMT-11 cl-9 cells was 9236±2829 pg/ml whereas that by 9 QR clones was 3411±2213 pg/ml (P 2 synthesis by QP clones (high-PGE2 producers) but also the s.c. growth of QP clones in mice. Chronological changes in host immune responses to tumor-associated antigen were measured by cytotoxic T lymphocyte (CTL) activity examined after mixed lymphocyte/tumor cell culture of spleen cells obtained from tumor-bearing mice. The CTL activity disappeared abruptly in the spleen of QP-clonebearing mice 21 days after the inoculation of tumors, whereas the spleen cells of QR-clone-inoculated mice retained their CTL activity. We determined that the mechanism responsible for the regression of these regressor clones is not due to any qualitative or quantitative increase in pre-existing membrane antigens, nor the emergence of new antigen(s) on the cell surface of the QR clones; nor was it due to enhanced susceptibility of QR clones to natural killer cells, lymphokine-activated killer cells and macrophages. These finding suggest that the regression mechanism of QR clones may be the diminished inhibition of host response to tumor-associated antigen caused by the reduced production of PGE2 by QR clones.Keywords
This publication has 41 references indexed in Scilit:
- Mutagenicity of quercetin in Chinese hamster lung cells in cultureMutation Research Letters, 1986
- Inhibition of Neutrophil Phospholipase A2 by p-Bromophenylacyl Bromide, Nordihydroguaiaretic Acid, 5,8,11,14-Eicosatetrayenoic Acid and QuercetinInternational Archives of Allergy and Immunology, 1985
- Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.The Journal of Experimental Medicine, 1984
- Possible epigenetic mechanisms of tumor progression: Induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatmentJournal of Cellular Physiology, 1984
- The augmentation of tumor‐specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus‐reactive helper T cellsEuropean Journal of Immunology, 1983
- Tumor-associated prostaglandins in patients with primary breast cancer: Relationship to clinical parametersBreast Cancer Research and Treatment, 1982
- Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolismLife Sciences, 1982
- Cytogenetic effects of quercetin on cultured mammalian cells.Proceedings of the Japan Academy, Series B, 1980
- Increased immunogenicity of low-antigenic rat tumors after superinfection with endogenous murine C-type virus in nude miceInternational Journal of Cancer, 1978
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977